OXFORD, England, July 15 --

- Senior Executives at Pfizer, Johnson Johnson, GlaxoSmithKline, and Other Big
Pharma use New Media to Bring Fresh Exchange

PharmaTelevision, the authoritative channel for the pharmaceutical,
biotechnology and related industries, announced today the launch of its new
service, PharmaTelevision Premium Content. PTV Premium Content will include PTV
News - a daily news and analysis service to be launched in August. Subscription
to the service will be free until 30 September, 2009. Dr Fintan Walton, CEO of
PharmaVentures - the company behind PharmaTelevision - said, Television captures
and delivers something unique, recognising that business is ultimately about the
people in it - whether it’s a part of deal making, or discovery and
development, or about a company’s ability to finance itself. It’s
not a surprise to us that PharmaTelevision has become ’must view’ TV
for many senior executives and managers.

Dr Walton continues, Launch of this new service means we can deliver to our
subscribers great television programming and integrated news and analysis
information services. PharmaTelevision addresses the current issues and future
predictions of the industry, including those of the top companies, through news,
analysis, interviews, panels and discussions. Interviewees come from companies
such as Johnson Johnson, Merck Co., sanofi-aventis, Genzyme, MerckSerono, NICE
UK, and Roche. As well as PTV News, current programmes include PharmaVentures
Business Review; The Regional Report; The Financial Report; and PharmaDeals(R)
Commentaries, and bring the major industry players straight to desktops - on
demand from the viewer.

Dr Walton says, This year, development to PharmaTelevision has been rapid as we
meet the demand from our discerning audience. Our subscribers can look forward
to significant upgrades that help them uncover further value in the service, and
not least will shortly see news services compiled jointly by top experts from
both the pharmaceutical and the television world. Subscribers to
PharmaTelevision Premium Content can access over 200 high quality interviews and
panel discussions filmed since June 2006. Dr Walton concludes, It’s an
exciting time for us and our viewers.

About PharmaTelevision(R)

PharmaTelevision (http://www.pharmatelevision.com) is the groundbreaking online
TV channel for the pharmaceutical and biotech sector, offering insight, featured
interviews, panel discussions and company information. Since May 2006,
PharmaTelevision has rapidly grown and the channel now boasts over 200 TV
programmes with a truly global audience, 60% of whom are C-suite executives. In
2008, the channel launched a sleek new look and introduced two exciting TV
programmes - the Financial Report and the Regional Report, which, together with
our well-established TV programmes, help to give our viewers a complete overview
of industry trends, analysis including deals, investments and strategic policies
within the sector. In 2009, PharmaTelevision will be launching PTV News - a
daily summary and analysis of the major news headlines, ensuring that, wherever
in the world they are, our audience can stay truly informed.

Testimonials about the value of PharmaTelevision from industry leading figures
can be viewed online at

A promotional Video about PharmaTelevision can be viewed online at:

PharmaTelevision is a part of the business media division of PharmaVentures Ltd

Notes to Editors:

About PharmaVentures

A leading results driven organisation, PharmaVentures (
http://www.pharmaventures.com) assists pharmaceutical and biotechnology
companies across the world in all aspects of deal making and business
intelligence. The Company’s provides tailored consulting and transaction
advisory services to the Life Science industry, with additional deal making
support provided through the PharmaDeals range of intelligence products that
include analysis tools and reports. An innovative business, PharmaVentures
additionally provides industry insight through the world’s first dedicated
online pharmaceutical television channel http://www.pharmatelevision.com.

Now in its 17th year PharmaVentures is based in Oxford, UK, employs over 50
people mostly educated to PhD or above, and has increased its turnover five fold
with 80% of revenues from outside the UK. With offices in the USA and Australia,
the Company works for a variety of clients from start-ups to global corporate
pharmaceutical companies.

For further information, or to receive a demonstration of the new service,
please contact:

Lisa Holloway Marketing, PharmaTelevision +44-(0)1865-784-177
lisa.holloway@pharmaventures.com Fintan Walton, +44-(0)1865-784-187

SOURCE: PharmaVentures

For further information, or to receive a demonstration of the new service,
please contact: Lisa Holloway, Marketing, PharmaTelevision, +44-(0)1865-784-177,
lisa.holloway@pharmaventures.com. Fintan Walton, +44-(0)1865-784-187